Navigation auf


Department of Adult Psychiatry and Psychotherapy

Psychedelic Research & Therapy Development (Dr. M. Scheidegger)

Our goal is to investigate the therapeutic potential of psychedelic compounds to reverse maladaptive neurobehavioral patterns in stress-related mood disorders and to enhance psychotherapeutic learning capabilities. The suboptimal efficacy of currently available drugs in mental health care points towards an unmet clinical need to investigate novel approaches to combine pharmacotherapy and psychotherapy. Recently, psychedelics such as ketamine, psilocybin, ayahuasca and DMT were discovered to alleviate symptoms of depression, anxiety, and addictive behaviors in a rapid-acting manner. Based on the findings from our neuroscientific research, we are developing novel transformation-based therapies for the safe, rapid-acting and sustainable treatment of affective disorders.


Weiterführende Informationen

Contact and Postal Address

Department of Psychiatry, Psychotherapy and Psychosomatics
Psychedelic Research & Therapy Development
University of Zurich
Lenggstrasse 31
CH-8032 Zurich

 Phone: +41 (0)44 384 2325



Unterseiten von Psychedelic Research & Therapy Development (Dr. M. Scheidegger)